The landscape of fibrotic interstitial lung diseases (ILDs) is undergoing a significant paradigm shift. While traditionally viewed through the lens of ...

PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...

The identification of unique pulmonary fibrosis endotypes is an important step in the development of precision medicine approaches for the incurable condition. Three distinct blood biomarker ...

If you have idiopathic pulmonary fibrosis (IPF), a chronic lung condition that can cause shortness of breath, low oxygen levels in the blood, and scarring on the lungs (fibrosis), it’s important to ...

Jascayd approval has been granted in Japan and recommended in the European Union for treating adults with two types of pulmonary fibrosis.

A new SPECT/CT imaging approach can accurately differentiate inflammation from fibrosis in interstitial lung disease (ILD) ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

VIENNA — Treatment with a novel lysophosphatidic acid receptor 1 (LPA1) antagonist was associated with significant changes in baseline biomarkers of disease in adults with pulmonary fibrosis, based on ...